This study investigates pancreatic cancer in people with new-onset or worsening diabetes mellitus. The purpose of this study is to explore the connection between diabetes and the risk of developing pancreatic cancer.
The study evaluates the potential for early detection of pancreatic cancer using MRI and blood samples. It focuses on understanding how diabetes might be linked to pancreatic cancer.
- Who can participate: Individuals aged 50 and above with diabetes are eligible. Participants must be able to undergo MRI and provide informed consent.
- Study details: Participants will have an MRI at the start and may have additional MRIs if needed. They will also give blood samples every 6 months for 3 years to help develop a screening test for pancreatic cancer.
- Study timelines: The study will last 3 years.
How understandable was the trial content above?
Hard to understand
Easy to understand